Vivimed Labs shareholding pattern
VIVIMEDLAB
9.28
0.86 (10.21%)Last updated on 1 Feb, 2026 | 15:26 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Summary
For Year 2025-26, Vivimed Labs reports the following shareholding: Total Promoters at 7.77%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 1.64%, Domestic Institutional Investors at 0.12%, and Retail at 90.48%. This breakdown provides a quick snapshot of ownership distribution for Vivimed Labs in 2025-26.
Vivimed Labs FAQs
As of 02-2026, the promoter shareholding in Vivimed Labs stands at 7.77% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Vivimed Labs is 1.64% and 0.12% respectively.
The retail shareholding of the Vivimed Labs is 90.48%.
Changes in shareholding patterns of Vivimed Labs can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Vivimed Labs are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
